Capecitabine
LDRT
Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversitySmall moleculePhase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 81/ 100
Competitive context
9 Active assets in the LDRT cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 1/2 | CCC |
Calcium folinate pentahydrate Zhejiang Provincial People's Hospital | Phase 1/2 | CC |
Pucotenlimab Zhejiang Provincial People's Hospital | Phase 1/2 | CC |
FLUOROURACILUM Zhejiang Provincial People's Hospital | Phase 1/2 | CC |
Irinotecan Zhejiang Provincial People's Hospital | Phase 1/2 | CC |
View all 9 →
Same molecule, other indications
Capecitabine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →